- call +1-201-465-4211
- email sales@mrinsights.biz
A migraine is a primary headache disorder characterized by recurrent headaches that are moderate to severe. Typically, the headaches affect one half of the head, are pulsating in nature, and last from two to 72 hours. Associated symptoms may include nausea, vomiting, and sensitivity to light, sound, or smell. The pain is generally made worse by physical activity.
Scope of the Report:
This report studies the Migraine market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Migraine market by product type and applications/end industries.
Globally, approximately 15% of people are affected by migraines. It most often starts at puberty and is worst during middle age. As of 2016 migraines is one of the most common causes of disability.
The global Migraine market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Migraine.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Allergan
Abbott Laboratories
Glaxosmithkline
Johnson & Johnson
Pfizer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Episodic
Chronic
Market Segment by Applications, can be divided into
Hospitals
Clinics
Home Care
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Migraine Market Overview
1.1 Product Overview and Scope of Migraine
1.2 Classification of Migraine by Types
1.2.1 Global Migraine Revenue Comparison by Types (2017-2023)
1.2.2 Global Migraine Revenue Market Share by Types in 2017
1.2.3 Episodic
1.2.4 Chronic
1.3 Global Migraine Market by Application
1.3.1 Global Migraine Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Global Migraine Market by Regions
1.4.1 Global Migraine Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Migraine Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Migraine Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Migraine Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Migraine Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Migraine Status and Prospect (2013-2023)
1.5 Global Market Size of Migraine (2013-2023)
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Business Overview
2.1.2 Migraine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Migraine Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott Laboratories
2.2.1 Business Overview
2.2.2 Migraine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbott Laboratories Migraine Revenue, Gross Margin and Market Share (2016-2017)
2.3 Glaxosmithkline
2.3.1 Business Overview
2.3.2 Migraine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Glaxosmithkline Migraine Revenue, Gross Margin and Market Share (2016-2017)
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 Migraine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Migraine Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Migraine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Migraine Revenue, Gross Margin and Market Share (2016-2017)
3 Global Migraine Market Competition, by Players
3.1 Global Migraine Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Migraine Players Market Share
3.2.2 Top 10 Migraine Players Market Share
3.3 Market Competition Trend
4 Global Migraine Market Size by Regions
4.1 Global Migraine Revenue and Market Share by Regions
4.2 North America Migraine Revenue and Growth Rate (2013-2018)
4.3 Europe Migraine Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Migraine Revenue and Growth Rate (2013-2018)
4.5 South America Migraine Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Migraine Revenue and Growth Rate (2013-2018)
5 North America Migraine Revenue by Countries
5.1 North America Migraine Revenue by Countries (2013-2018)
5.2 USA Migraine Revenue and Growth Rate (2013-2018)
5.3 Canada Migraine Revenue and Growth Rate (2013-2018)
5.4 Mexico Migraine Revenue and Growth Rate (2013-2018)
6 Europe Migraine Revenue by Countries
6.1 Europe Migraine Revenue by Countries (2013-2018)
6.2 Germany Migraine Revenue and Growth Rate (2013-2018)
6.3 UK Migraine Revenue and Growth Rate (2013-2018)
6.4 France Migraine Revenue and Growth Rate (2013-2018)
6.5 Russia Migraine Revenue and Growth Rate (2013-2018)
6.6 Italy Migraine Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Migraine Revenue by Countries
7.1 Asia-Pacific Migraine Revenue by Countries (2013-2018)
7.2 China Migraine Revenue and Growth Rate (2013-2018)
7.3 Japan Migraine Revenue and Growth Rate (2013-2018)
7.4 Korea Migraine Revenue and Growth Rate (2013-2018)
7.5 India Migraine Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Migraine Revenue and Growth Rate (2013-2018)
8 South America Migraine Revenue by Countries
8.1 South America Migraine Revenue by Countries (2013-2018)
8.2 Brazil Migraine Revenue and Growth Rate (2013-2018)
8.3 Argentina Migraine Revenue and Growth Rate (2013-2018)
8.4 Colombia Migraine Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Migraine by Countries
9.1 Middle East and Africa Migraine Revenue by Countries (2013-2018)
9.2 Saudi Arabia Migraine Revenue and Growth Rate (2013-2018)
9.3 UAE Migraine Revenue and Growth Rate (2013-2018)
9.4 Egypt Migraine Revenue and Growth Rate (2013-2018)
9.5 Nigeria Migraine Revenue and Growth Rate (2013-2018)
9.6 South Africa Migraine Revenue and Growth Rate (2013-2018)
10 Global Migraine Market Segment by Type
10.1 Global Migraine Revenue and Market Share by Type (2013-2018)
10.2 Global Migraine Market Forecast by Type (2018-2023)
10.3 Episodic Revenue Growth Rate (2013-2023)
10.4 Chronic Revenue Growth Rate (2013-2023)
11 Global Migraine Market Segment by Application
11.1 Global Migraine Revenue Market Share by Application (2013-2018)
11.2 Migraine Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Home Care Revenue Growth (2013-2018)
12 Global Migraine Market Size Forecast (2018-2023)
12.1 Global Migraine Market Size Forecast (2018-2023)
12.2 Global Migraine Market Forecast by Regions (2018-2023)
12.3 North America Migraine Revenue Market Forecast (2018-2023)
12.4 Europe Migraine Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Migraine Revenue Market Forecast (2018-2023)
12.6 South America Migraine Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Migraine Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Migraine Picture
Table Product Specifications of Migraine
Table Global Migraine and Revenue (Million USD) Market Split by Product Type
Figure Global Mig
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
